Global Product Supply
It is LEO Pharma's goal to establish the most efficient and professional Global Product Supply set-up to support product sales, and ensure the best quality and rapid delivery of LEO products to customers at a reasonable cost.
To deliver this, the Global Product Supply organisation is committed to continuous improvements within customer service, production costs, product quality and compliance.
Pharmaceutical manufacturing plants are subject to international rules of Good Manufacturing Practice (GMP) and quality assurance. Plants involved in supply to the US are approved by the US Federal Drug Administration (FDA).
More than 950 employees work in our six production plants situated in Denmark, France, Ireland, and Australia;
